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ABSTRACT
Gynecomastia is a condition in which 3% of males will go on to develop permanent
excess breast tissue and has been associated with a number of psychosocial consequences. In
recent years, gynecomastia surgery has been in the top 5 cosmetic procedures sought out by men.
There is a limited amount of research regarding psychosocial outcomes of gynecomastia surgery
despite the large number of men seeking surgery, and the current literature on outcomes has yet
to examine chest satisfaction within the context of gynecomastia surgery. The current study
sought to add to the treatment literature on gynecomastia by examining chest satisfaction,
appearance evaluation, chest-related state anxiety, general trait anxiety, self-esteem, depressive
symptoms, eating pathology, and various facets of health-related quality of life, before and after
surgery. Mixed effects models were used to examine change at baseline, 1 month post-op, 3
months post-op, 6 months post-op, and 12 months post-op. Paired samples t-tests were used to
examine change from baseline to 12 months post-op. Additionally, it may be that chest
satisfaction in this population has not been examined due to limited body image measures that
tap into this construct. Therefore, another aim of this study was to examine the psychometrics of
a newly created chest satisfaction measure. The results from the current study showed significant
improvement in chest satisfaction and appearance evaluation from baseline to 12 months postop. Additionally, chest-related anxiety significantly decreased, and social functioning
significantly improved over time. The current study also provided preliminary psychometric
support for the Chest Satisfaction Questionnaire. Taken together, these findings may indicate the
potential for chest-specific and body image-related variables to improve following gynecomastia
vi

surgery and provide a new measure that can be used to assess chest satisfaction within the
gynecomastia population.
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CHAPTER ONE: INTRODUCTION
Gynecomastia involves excess glandular growth of breast tissue in males affecting either
one (unilateral) or both (bilateral) sides of the chest. Gynecomastia is estimated to affect
anywhere from 30 to 70% of males in the course of their lifetime, with increased prevalence
during the neonatal period, adolescence, and older adulthood (Cakan & Kamat, 2007; Gikas &
Mokbel, 2007; Johnson, Kermott, & Marod, 2011; Nordt & DiVasta, 2008; Nydick, Bustos,
Dale, & Rawson, 1961). Recent research indicates the highest prevalence during the neonatal
period (60-90%), followed by similar incidence rates during adolescence and old age (50-70%,
Johnson, Kermott, & Marod, 2011). Such high prevalence rates would sound alarming; however,
gynecomastia is transient in nature, with most cases remitting within 3 years of onset (Cakan &
Kamat, 2007; Gikas & Mokbel, 2007; Nydick et al., 1961). While most cases resolve on their
own, some cases of gynecomastia are permanent, leaving upwards of 6% of affected individuals
with excess breast tissue indefinitely. Moreover, this proliferation of breast tissue is often
incongruent with gender identity when experienced unintentionally (Money & Lewis, 1982;
Schonfeld, 1962; Wassersug & Oliffe, 2009). This development of opposite sex characteristics
can have lasting consequences on psychosocial functioning and body image. While minimal
psychological research exists within the unique population of males with gynecomastia, recent
research suggests a host of negative psychosocial consequences associated with gynecomastia
(e.g., Ordaz & Thompson, 2015).
Internalizing symptoms, primarily consisting of depression, anxiety, and reduced selfesteem, are the most commonly cited problems associated with gynecomastia (e.g., Ordaz &
1

Thompson, 2015). For example, multiple studies examining youth with gynecomastia
demonstrate elevated levels of depressive and anxiety symptoms when compared to population
norms (Kinsella et al., 2012; Storch et al., 2004). Such symptoms culminate into a diagnosable
mood disorder in 17% of cases and a diagnosable anxiety disorder in approximately 25% of
cases (Kinsella et al., 2012). Additionally, this research has suggested heightened risk for
loneliness in this population (Storch et al., 2004), which may be associated with maladaptive
coping behaviors seen in those with gynecomastia. For example, many individuals with
gynecomastia report socially withdrawing or isolating themselves in response to gynecomastia,
as well as avoiding situations in which their chest might be exposed (Money & Lewis, 1982;
Rosen et al., 2010; Schonfeld, 1962). Such social isolation is frequently associated with
depressive symptoms and is consistent with the experience of social or appearance-related
anxiety. As evidenced, gynecomastia is often associated with a multitude of emotional
consequences and significant distress, yet it remains understudied in behavioral health
psychology.
In addition to social withdrawal and avoidance, gynecomastia is often associated with
efforts to self-treat through a variety of maladaptive coping strategies. For example, individuals
with gynecomastia report wearing multiple shirts, wrapping their chest in duct tape, and making
harmful postural adjustments in order to hide the appearance of the chest (Kinsella et al., 2012).
Such behaviors mimic those often seen in cases of body dysmorphic disorder, in which
individuals hide perceived flaws through use of clothing or makeup. Moreover, behavioral
components of traditional eating disorders have been endorsed by the gynecomastia population
in an attempt to change the appearance of the chest. For example, one case study described
vomiting and excessive exercise in two adolescent boys with gynecomastia, which were used as

2

attempts to change the appearance of their chest (Fisher & Fornari, 1990). Other research
highlights food restriction as a means of trying to self-treat gynecomastia (Kinsella et al., 2012).
Additionally, more recent research highlights differences between males with and without
gynecomastia on disordered eating measures, though this may be due to a higher BMI associated
with gynecomastia (Nuzzi et al., 2013). Such maladaptive coping behaviors in an attempt to
either hide or change the appearance of the chest indicates significant distress associated with
gynecomastia and an increased effort to self-treat through pathological means. Moreover, it
highlights the need for more treatment-focused research within this population, as attempts to
self-treat concerns associated with gynecomastia are likely to do more harm than good.
Treatment options for gynecomastia are limited, especially during earlier stages of
development where there is more hesitance to treat the condition. This lack of early intervention
may be why individuals with gynecomastia find the need to self-treat through a variety of
maladaptive coping mechanisms. For example, sympathetic reassurance from health-care
professionals consisting of reassuring those with gynecomastia of its transient nature and
monitoring of the condition is commonly cited as the primary form of action taken for earlyonset gynecomastia (Cakan & Kamat, 2007; Nordt & DiVasta, 2008; Nydick et al., 1961).
Meanwhile, it is likely that adolescents with gynecomastia may still endorse efforts to self-treat
their gynecomastia through pathological eating- and body-related behaviors in this stage of
development as evidenced by previous research (Fisher & Fornari, 1999; Kinsella et al., 2012).
When gynecomastia is deemed permanent, patients are typically referred to a cosmetic surgeon
for a combination of glandular removal of breast tissue and liposuction (Gikas & Mokbel, 2007;
Johnson & Murad, 2009; Nordt & DiVasta 2008). In fact, according to an American Society of
Plastic Surgeons (2017) statistical report, breast reduction for gynecomastia has recently been in
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the top five most frequently sought cosmetic surgery procedures for males, and the number of
breast reduction procedures has increased from previous years.
While an abundance of research exists outlining a variety of surgical techniques for
gynecomastia, the research concerning psychological outcomes of surgery is scant, and such
research shows conflicting results. For example, some research suggests high satisfaction rates
with surgery (e.g., Barone et al., 2017) and increases in self-esteem (Fricke, Lehner, Stark, &
Penna, 2017) and quality of life (Davanco et al., 2009; Kasielska-Trojan & Antoszewski, 2017;
Nuzzi et al., 2018). Other work, however, suggests that surgery alone is inadequate for reducing
psychological distress and improving self-esteem (Davanco et al., 2009; Schonfeld, 1962).
Moreover, most individuals with gynecomastia report some form of dissatisfaction with the
appearance of their chest as motivation for trying to change the appearance of their chest either
on their own or through surgery (Fisher & Fornari, 1990; Schonfeld, 1962; Wassersug & Oliffe,
2009), yet no research to date quantitatively examines the impact of surgery on gynecomastiarelated body image. Instead, satisfaction rates with surgery have commonly served as a proxy for
chest satisfaction. The primary goal of surgery for gynecomastia is often to remove glandular
breast tissue and create a more masculine appearance of the chest. As such, it would be
informative to know if such procedures do in fact improve patients’ body image, yet the current
evidence remains unclear.
Despite growing evidence of psychosocial distress associated with gynecomastia and
increasing rates of breast reduction surgeries for males, no research to date has quantitatively
examined body image outcomes in this population (e.g., Ordaz & Thompson, 2015). Yet, body
image has garnered attention in the context of other similar surgical procedures. Assessing body
image concerns within a surgical context can provide insight into the motives for seeking
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treatment and the effectiveness of such procedures on body satisfaction (Sarwer & Crerand,
2004). For example, previous studies have examined body image outcomes in women seeking
cosmetic surgery for a variety of reasons including general appearance enhancement and
reconstructive purposes (Sarwer, Wadden, & Whitaker, 2002; Schover et al., 1995; von Soest,
T., Kvalem, Roald, & Skolleborg, 2009). Macromastia occurs when women develop increased
breast tissue and is commonly associated with pain and psychosocial distress (Cerrato et al.,
2012; Iwuagwu, Stanley, Platt, Drew, & Walker, 2006; Pérez-Panzano, et al., 2017; Sarwer et al.,
1998). In the context of female breast reduction, surgery is associated with improvements in
body satisfaction and other psychosocial factors (Borkenhagen, Röhricht, Prei, Schneider, &
Brähler, 2007; Glatt et al., 1999; Iwuagwu et al., 2006; Pérez-Panzano, et al., 2017; Rogliani,
Gentile, Labardi, Donfrancesco, & Cervelli, 2009). While gynecomastia and macromastia share
many similarities, there remains a gap in the body image literature when it comes to abnormal
breast development in males, perhaps due to a lack of appropriate body image measures for the
gynecomastia population.
The field of male body image has largely focused on muscularity and fat concerns (Cafri
& Thompson, 2004; Tiggemann, Martins, & Churchett, 2008), resulting in body image measures
that tap into such constructs, yet none capture chest satisfaction as it might relate to
gynecomastia. For example, the Body Areas Satisfaction Scale is a site-specific body image
measure that assesses satisfaction with a number of different body sites (e.g., lower torso, upper
torso, face, etc.), but it does not assess chest satisfaction specifically (Cash, 2000). A similar
measure exists specifically for men that includes items addressing the chest/upper torso – The
Body Parts Satisfaction Scale for Men (BPSS-M; McFarland & Petrie, 2012). This measure,
however, focuses on satisfaction with leanness and muscularity rather than chest appearance
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more generally. The Chest Rating Scale (CRS), a silhouette scale portraying male figures with
varying levels of muscularity, also assesses muscularity-oriented body dissatisfaction with the
torso (Thompson & Tantleff, 1992). Such scales are useful when looking at body image relevant
to muscularity, but gynecomastia and its surgical intervention are independent of muscularity,
making the BPSS-M and CRS less appropriate for this population. While individuals with
gynecomastia may be influenced by the muscular ideal, body image in this population may be
more strongly influenced by the appearance of the chest specifically, versus general indices of
muscularity and body fat. Given that gynecomastia surgery is often sought out specifically to
improve the appearance of the chest through removal of breast tissue, a psychometrically strong
chest-specific body image measure is warranted.
The Current Study
The first aim of this study used longitudinal data to examine psychosocial functioning
over time in men who had undergone gynecomastia surgery. Given past research suggesting the
potential for improvements in health-related quality of life after surgical gynecomastia treatment
(Davanco et al., 2009; Kasielska & Antoszewski, 2011), I hypothesized that participants would
exhibit improved quality of life following surgery. While there are no data to suggest
quantitative improvements in body image following gynecomastia surgery, there is research to
suggest high satisfaction rates with this type of surgery (e.g., Barone et al., 2017). While to date
no studies have explicitly measured pre- and post-surgery chest satisfaction, I hypothesized that
satisfaction with surgery would generalize to increased chest satisfaction following surgery.
Additionally, some research has attempted to examine the effects of surgery on self-esteem
producing mixed findings (Davanco et al., 2009; Fricke, Lehner, Stark, & Penna, 2017;
Schonfeld, 1962); thus, it is unclear how self-esteem will be impacted following surgery based
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on previous research. Other psychological factors (e.g., depressive symptoms, anxiety, eating
pathology, and global appearance evaluation) have yet to be examined in a treatment context
within this population; thus, analyses regarding these psychological outcomes were exploratory
in nature.
The second aim was to examine the psychometrics of a newly developed chest
satisfaction measure. This aim included examining the factor structure of the measure and
assessing reliability and convergent validity. Additionally, as there is also a significant amount of
research examining body image in the context of macromastia (Borkenhagen et al., 2007; Glatt et
al., 1999; Perez-Panzano et al., 2017), the factor structure of the new chest satisfaction measure
was examined in both men and women with the goal of producing a psychometrically sound
measure of chest satisfaction that works similarly for men and women. Such a measure could
prove useful for cosmetic and reconstructive surgery, especially for gynecomastia, as satisfaction
with the surgical procedure is currently serving as a proxy for chest satisfaction. Convergent
validity for the chest satisfaction measure was investigated by examining its association with
other psychosocial variables of interest (e.g., appearance evaluation, eating pathology,
appearance anxiety, and self-esteem) in three separate groups: men with gynecomastia, men
without gynecomastia, and women.
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CHAPTER TWO: METHOD
Participants
For the first aim, a group of 25 men with gynecomastia presenting for breast reduction
surgery, between the ages of 18 and 65, was recruited. For the second aim, an additional 183
men and 280 women were recruited. The second aim consisted of three different subsamples: 98
men with gynecomastia (including the 25 from aim one), 110 men without gynecomastia, and
280 women.
Aim 1 Procedure
Participants were recruited from an outpatient plastic surgery center in Orlando, Florida,
prior to receiving gynecomastia surgery. The surgeon at the outpatient surgery center had several
years of experience in providing gynecomastia surgery, utilizing combined mastectomy and
liposuction. Individuals were considered appropriate for this study if they currently had
gynecomastia, signed up for surgery at the clinic, and were between the ages of 18 and 65. Thirty
men were approached about the study, and 25 consented and agreed to participate. Upon
consenting to the study, participants were awarded $20 dollars as compensation for their time.
Participants completed a baseline questionnaire within a week prior to surgery, and then
completed surveys at 4 additional time points post-surgery: 1 month, 3 months, 6 months, and 12
months. These five time points were chosen considering recovery time as well as longitudinal
change. See Appendix A for a timeline of study time points.
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Baseline Assessment
After the initial consultation with the surgeon, the plastic surgery coordinator informed
patients about the study and obtained informed consent. Participants were given an iPad with a
link to the online survey hosted by SurveyMonkey. Participants provided their age, height, and
weight and completed seven psychological measures. Completion of these measures took
approximately 20 minutes. The plastic surgery coordinator was available to answer any
procedural questions regarding the study, and if participants preferred to complete the measures
at home, they were emailed a link to the survey to complete prior to surgery. Baseline surveys
were completely within one week prior to surgery for all participants.
Follow-up Assessments
When participants had scheduled follow-up visits at the surgery center, they were given
the option to complete the online follow-up survey(s) via an iPad given to them by the plastic
surgery coordinator, or on their own time through a survey link that was emailed to them by a
member of the study team. These time points took place 1 month, 3 months, 6 months, and 12
months following surgery. Participants were sent a weekly reminder email and phone text to
complete their survey by a member of the study team at each follow up, with weekly reminders
being sent until the last week they were able to complete follow-up surveys. Participants were
allowed to complete follow-up surveys up to half-way until the next follow-up appointment.
Specifically, participants had four weeks to complete the 1 month follow-up (time point 2), six
weeks to complete the 3 month follow-up (time point 3), 12 weeks to complete the 6 month
follow-up (time point 4), and 24 weeks to complete 12 month follow-up (time point 5).
Participants self-reported their height and weight and completed all seven psychological
measures at time points two through five.
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Aim 2 Procedure
Aim 2 included men with gynecomastia, as well as comparison groups of men without
gynecomastia and women. The 25 men with gynecomastia recruited for aim 1 were also included
in aim 2. An additional group of men with gynecomastia were recruited from an online forum for
gynecomastia (gynecomastia.org) to increase the total sample size. An IRB-approved forum post
provided a brief study description and a direct link to the questionnaires to recruit participants
(see Appendix B for the forum post). Men were allowed to participate in the study if they had
gynecomastia and were between the ages of 18 and 65. Participants were able to reach out to the
study team via email or phone if they had questions prior to participating.
Men and women were recruited through the psychology participant pool (SONA) at the
University of South Florida to generate non-gynecomastia comparison samples. Out of the men
who participated, 2% endorsed gynecomastia. Students at the university were able to participate
in the study if they were between the ages of 18 and 65. Participants recruited from these sources
were asked to complete a one-time assessment of their age, height, weight, and seven
psychological measures. Participants from gynecomastia.org and SONA were recruited and
provided informed consent completely online prior to completing questionnaires. Participants
from SONA were given extra credit points for participation in the study.
IRB Approval
Both aim 1 and aim 2 were submitted to the University of South Florida’s Institutional
Research Board (IRB) as one study. The study was approved at the expedited level.
Measures
All participants provided their age, height, and weight and completed the seven
psychological measures listed below.
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Patient Health Questionnaire-9 (PHQ-9)
The PHQ-9 (Spitzer, Kroenke, & Williams, 1999) is a self-report depression severity
scale commonly used in medical settings with questions pertaining to the nine depression criteria
based on the Diagnostic and Statistical Manual of Mental Disorders - IV (DSM-IV). The
measure consists of 10 items, with the first 9 items asking the patient how often they have been
bothered by each problem over the last two weeks and an additional item at the end for patients
who checked off any of the symptoms asking: “How difficult have these problems made it for
you to do your work, take care of things at home, or get along with other people?” For the
purpose of this study, the time frame was changed to three weeks. One question asks about
suicidal ideation. All participants were given potential resources for suicidal ideation at the top
of each measure and at the final page of the online survey. Each question is answered on a scale
of 0 (not at all) to 3 (nearly every day), and the measure is scored by adding the scores for the
first nine questions with a possible score of 0 to 27. The total score indicates depression severity,
with 1-4 indicating minimal depression, 5-9 indicating mild depression, 10-14 indicating
moderate depression, 15-19 indicating moderately severe depression, and 20-27 indicating severe
depression. Internal consistency was acceptable to good, with Cronbach’s alphas of .75, .88, .89,
and .88 for men with gynecomastia receiving surgery, men with gynecomastia, men without
gynecomastia, and women respectively. See Appendix C for the full measure.
State Trait Anxiety Index – Y Form (STAI-Y)
The STAI-Y (Spielberger, 1983) is a self-report measure of state and trait anxiety. The
measure consists of two forms, Y-1 and Y-2. Y-1 consists of 20 state anxiety questions asking
participants to rate how they feel “right now” on a scale of 1 (not at all) to 4 (very much so), and
Y-2 consists of 20 trait anxiety questions asking participants to rate how they feel “generally” on
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a scale of 1 (almost never) to 4 (almost always). The state anxiety questions of the measure are
able to reflect a certain situation rather than how the person feels “right now.” As such, the
questions regarding state anxiety were changed from “right now” to “when your chest is exposed
(wearing a thin shirt, a tight shirt, or no shirt at all).” A sample statement for the state anxiety
questions is, “I feel self-confident.” A sample statement for the trait anxiety questions is, “I feel
like a failure.” Scores can range from 20 to 80 for each form by summing the weighted scores.
Items 1, 2, 5, 8, 10, 11, 15, 16, 19, and 20 on form Y-1 are reverse coded. Items 21, 23, 26, 27,
30, 33, 34, 36, and 39 on form Y-2 are reverse coded. Higher scores on form Y-1 indicate greater
chest-related state anxiety while higher scores on form Y-2 indicate greater trait anxiety. For the
state anxiety subscale, internal consistency was excellent, with Cronbach’s alphas of .95, .97,
.95, and .94 for men with gynecomastia receiving surgery, men with gynecomastia, men without
gynecomastia, and women respectively. For the trait anxiety subscale, internal consistency was
excellent, with Cronbach’s alphas of .94, .96, .95, and .94 for men with gynecomastia receiving
surgery, men with gynecomastia, men without gynecomastia, and women respectively. See
Appendix D for the full measure.
Eating Disorders Inventory – Drive for Thinness and Bulimia (EDI-DT and B)
The EDI (Garner, Olmstead, and Polivy, 1983) is a self-report multidimensional measure
of feelings, attitudes, and behaviors regarding eating. For the purpose of this study the drive for
thinness (DT) and bulimia (B) subscales were used to assess eating pathology. Both subscales
consist of 7 items totaling to 14 items. Participants are asked to rate how often each statement
applies on a scale from 1 (always) to 6 (never). A sample statement is: “I think about dieting.”
Typically, when a participant indicates 1, 2, or 3, his score is 3, 2, or 1, respectively for that item
while indicating 4, 5, or 6 earns a score of 0. For ease of examining eating pathology on a
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continuum, scores will remain on a scale from 1 to 6 with the first item being reverse scored.
When this approach is taken, subscale scores are then summed (Schoemaker, van Strien, & van
der Staak, 1994). Total subscale scores can range from 7 to 42. Higher scores indicate greater
eating pathology. For the drive for thinness subscale, internal consistency ranged from good to
excellent, with Cronbach’s alphas of .90, .87, .90, and .92 for menmales with gynecomastia
receiving surgery, men with gynecomastia, men without gynecomastia, and women respectively.
For the bulimia subscale, internal consistency ranged from acceptable to excellent, with
Cronbach’s alphas of .79, .93, .84, and .88 for men with gynecomastia receiving surgery, men
with gynecomastia, men without gynecomastia, and women respectively. See Appendix E for the
full measure.
Rosenberg Self-Esteem Scale (RSES)
The RSES (Rosenberg, 1965) is a commonly used measure of global self-esteem. The
measure consists of 10 statements pertaining to self-esteem and self-worth to be rated on a 4point scale ranging from strongly agree to strongly disagree. A sample statement is: “I feel that I
have a number of good qualities.” Strongly agree is weighted at 0, and strongly disagree is
weighted at 3. Items 2, 5, 6, 8, and 9 are reverse coded, and scoring consists of summing the
scores. Total scores can range from 0 to 30. Higher scores indicate greater self-esteem. Internal
consistency ranged from good to excellent, with Cronbach’s alphas of .89, .92, .92, .92 for men
with gynecomastia receiving surgery, men with gynecomastia, men without gynecomastia, and
women. See Appendix F for the full measure.
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Multidimensional Body Self-Relations Questionnaire – Appearance Evaluation
Scale (MBSRQ-AE)
The appearance evaluation subscale of the MBSRQ-AE (Cash, 2000) is a seven-item
measure of global appearance evaluation. Participants are asked to rate their agreement with
seven statements concerning how they feel about their body or appearance on a scale from 1
(definitely disagree) to 5 (definitely agree). A sample statement is: “My body is sexually
appealing.” Scores are averaged, and items 6 and 7 are reverse scored. Total scores can range
from 1 to 5, and higher scores indicate greater appearance evaluation. Internal consistency
ranged from good to excellent, with Cronbach’s alphas of .84, .89, .92, and .91 for men with
gynecomastia receiving surgery, men with gynecomastia, men without gynecomastia, and
women respectively. See Appendix G for the full measure.
Chest Satisfaction Questionnaire (CSQ)
The CSQ is an eight-item measure of chest satisfaction that was developed in a previous
study (Ordaz, 2016). During the development process, a pool of questions was created and
modeled after the MBSRQ-AE. After expert review, eight questions were retained and internal
consistency was deemed excellent in a sample of men with gynecomastia. Similar to the
MBSRQ-AE, participants are asked to rate their agreement with seven statements concerning
how they feel about their chest on a scale from 1 (definitely disagree) to 5 (definitely agree). A
sample statement is: “I am comfortable with the shape of my chest.” Scores are averaged, and
item 4 is reverse coded. Total scores can range from 1 to 5, and higher scores indicate greater
chest satisfaction. Internal consistency ranged from poor to excellent, with Cronbach’s alphas of
.69, .91, .94, and .90 for men with gynecomastia receiving surgery, men with gynecomastia, men
without gynecomastia, and women respectively. See Appendix C for the full measure.
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Short Form – 36 Version 2.0 (SF-36 V2)
The SF-36 V2 (Ware, Kosinski, & Dewey, 2000) is a widely used measure of healthrelated quality of life that measures multiple domains of quality of life. For the purpose of this
study, six of the eight subscales were used: bodily pain (BP), general health (GH), vitality (VT),
social functioning (SF), role-emotional (RE), and mental health (MH). These subscales were
picked based on topics of interest for this study, as well as past research suggesting these
domains are particularly relevant to gynecomastia (Davanco et al., 2009; Nuzzie et al., 2013).
These subscales total to 21 items. Statements related to physical health, mental health, and
quality of life are rated on 5- to 6-point likert scales. A sample item is: “During the past 3 weeks,
to what extent has your physical health or emotional problems interfered with your normal social
activities with family, friends, neighbors, or groups?” Domain scores are transformed into scaled
scores ranging from 0 to 100, and items 9, 10, 13, 14, 16, 18, and 20 are reverse coded. Higher
scores indicate greater health-related quality of life. Internal consistency ranged from good to
excellent, with Cronbach’s alphas of .94, .93, .89, and .91 for men with gynecomastia receiving
surgery, men with gynecomastia, men without gynecomastia, and women respectively. See
Appendix I for the full measure.
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CHAPTER THREE: DATA ANALYSES
As there is not enough research to extrapolate effect sizes for surgery on relevant
outcomes, scatter plots from the longitudinal data were used to estimate effect sizes.
Examination of scatter plots revealed potential for medium effects of surgery on related
outcomes. As such, an effect size of f = .25 was used for power analyses. Post-hoc power
analyses were calculated for within factors, repeated measures ANOVA, a similar, but more
conservative method than linear mixed-effects modeling (Krueger & Tian, 2004). As such, the
proposed analyses should have sufficient power to detect effects. SPSS 25.0 and G*Power 3.1
were used for power analyses. With the noted effect size and five repeated measurements, a total
sample size of 21 was estimated to achieve .80 power. The current sample size of 25 participants
allowed for sufficient power to detect medium effect sizes.
For aim 1, linear mixed-effects models were used to examine symptom change over time
for all outcomes of interest (depressive symptoms, chest-related state anxiety, trait anxiety,
eating pathology, self-esteem, appearance evaluation, chest satisfaction, and health-related
quality of life), with a fixed effect of time and random intercept and  = .05 in SPSS 25.0. As
spacing between time points was not equal, the time variable reflected months since surgery. Full
Information Maximum Likelihood (FIML) estimation was used for all analyses to account for
missing data. There was a significant amount of data lost at follow up, with time points 1 through
5 having 4%, 45%, 50%, 45%, and 65% missing data respectively. Paired samples t-test was also
used to examine pre to post change and Cohen’s d was used for effect size. A one-way ANOVA
was used to assess differences on age, BMI, and all outcome variables between participants who
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completed versus did not complete the study. Completers and non-completers did not
significantly differ on any variable. Differences in descriptive statistics across men with
gynecomastia presenting for surgery, men with gynecomastia, and men without gynecomastia
were examined for aim 1 using a one-way ANOVA. Post-hoc differences were examined using
Tukey HSD when variances were equal and Games-Howell when variances were not equal. Etasquared (η2) was used for estimates of effect size. All analyses were done using SPSS 25.0.
Separate analyses were used to examine the effects of time on the following dependent
variables (DVs): depressive symptoms, chest-related state anxiety, trait anxiety, eating
pathology, self-esteem, appearance evaluation, chest satisfaction, and various facets of healthrelated quality of life. Models were first run with an added random factor of time, but they did
not converge. This random factor was removed from subsequent models. While this resulted in
losing some information from the models, it also allowed for greater flexibility. For each
analysis, Model 1 included a fixed factor of time and a random factor of intercept. Model 2
included an additional fixed factor of baseline BMI to assess whether controlling for BMI
provided a better fit for the data. This decision was made on the basis that some of the variables
of interest (e.g., body image related variables) are often correlated with BMI (Weinberger,
Kersting, Riedel-Heller, & Luck-Sikorski, 2016). For non-body image dependent variables, BMI
was retained in the models for consistency. Lastly, Model 3 included an additional fixed factor of
the interaction between baseline BMI and time to assess whether baseline BMI influenced
change in outcomes over time. Moderation was further assessed using computational procedures
and guidelines for interpreting multilevel modeling interactions provided by Preacher, Curran, &
Bauer (2006), using simple slopes for the mean level of the moderator and at ± 1 standard
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deviation of the moderator. An autoregressive covariance structure was specified on the basis
that measurement points would be less correlated with each other the farther apart in time.
For aim 2, the factor structure for the CSQ was examined in a combined sample of men
(with and without gynecomastia) and a sample of women. An exploratory factor analysis (EFA)
using principal axis factoring and promax oblique rotation was used to examine the factor
structure of the CSQ in SPSS 25.0. The decision to use promax oblique rotation was made as
underlying factors, should there be more than one, are expected to correlate. A statistically
significant Bartlett’s test of sphericity and a Kaiser-Meyer-Olkin value at or above .60 was used
to determine appropriate items (Tabachnick & Fidell, 2007). The scree plot (Floyd & Widaman,
1995; Cattell, 1966), Kaiser-Guttman criterion of an eigenvalue of 1.0 or greater (Guttman,
1954; Kaiser, 1960), and parallel analysis using 1000 samples (Horn, 1965), was used to
determine the number of factors. Item factor loadings were assessed, and items with at least a .40
factor loading were retained (Floyd & Widaman, 1995; Ford, MacCallum, & Tait, 1986). There
was 3% missing data for the sample of men and 6% missing data for the sample of women.
Listwise deletion was used for missing data. Similarity between factor structures of the CSQ for
men and women was assessed using Tucker’s coefficient of congruence, with a coefficient of
.85-.94 suggesting fair similarity and a coefficient of .95 or greater suggesting equal factors
(Lorenzo-Seva & ten Berge, 2006). Additionally, separate correlation matrices including all
variables of interest were created for men with gynecomastia, men without gynecomastia, and
women to examine patterns of associations between chest satisfaction and other indices of
mental health within these groups and to examine convergent validity for the CSQ. Lastly,
differences in descriptive statistics between men (with and without gynecomastia) and women
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were examined for aim 2 using independent samples t-tests in SPSS 25.0. Levene’s test was used
to assess equality of variances and Hedge’s g was calculated for effect sizes.
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CHAPTER FOUR: RESULTS
Aim 1
Results from the one-way ANOVA showed significant differences on a number of
variables when comparing men with gynecomastia presenting for surgery, men with
gynecomastia, and men without gynecomastia. Significant differences were found for the
following variables: age (F(2, 230) = 60.24, p < .001, η2 = .34), BMI (F(2, 230) = 5.51, p < .01,
η2 = .05), chest satisfaction (F(2, 223) = 67.34, p < .001, η2 = .38), appearance evaluation (F(2,
223) = 25.00, p < .001, η2 = .18), drive for thinness (F(2, 219) = 10.44, p < .001, η2 = .09), chestrelated state anxiety (F(2, 206) = 19.59, p < .001, η2 = .16), general trait anxiety (F(2, 206) =
3.52, p < .05, η2 = .03), self-esteem (F(2, 221) = 5.44, p < .01, η2 = .05), depressive symptoms
(F(2, 217) = 3.05, p < .05, η2 = .03), bodily pain (F(2, 226) = 4.02, p < .05, η2 = .03), and social
functioning (F(2,222) = 7.19, p < .01, η2 = .06). For post-hoc differences, see Appendix D. There
were no significant differences on the following variables: bulimia (F(2, 216) = 2.99, p = .05, η2
= .03), health-related quality of life (F(2, 198) = 2.39, p = .09, η2 = .02), general health (F(2,
205) = 1.12, p = .33, η2 = .01), vitality (F(2, 224) = 1.25, p = .29, η2 = .01), role emotional (F(2,
229) = 1.41, p = .25, η2 = .01), and mental health (F(2, 222) = 2.55, p = .08, η2 = .02). Overall,
the surgery group was similar to the larger gynecomastia group with a few exceptions. The
surgery group experienced significantly more chest dissatisfaction, significantly less depression,
and significantly greater quality of life related to bodily pain.
Results for the paired samples t-test showed a significant difference from baseline to 12
month follow-up for chest satisfaction (t(9) = -5.31, p < .001, d = 1.69) and appearance
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evaluation (t(8) = -4.92, p < .01, d = 1.65), such that both chest satisfaction and appearance
evaluation significantly improved at 12 month follow-up. The following variables did not
significantly change based on the paired samples t-test: BMI (t(9) = -.97, p = .36, d = .31),
health-related quality of life (t(7) = .56, p = .59, d = .20), bodily pain (t(8) = .62, p = .55, d =
.21), general health (t(7) = 1.07, p = .32, d = .38), vitality (t(8) = .38, p = .72, d = .13), social
functioning (t(8) = -1.21, p = .26, d = .40), role emotional (t(8) = .40, p = .70, d = .13), mental
health (t(8) = .36, p = .73, d = .12), drive for thinness (t(8) = 1.70, p = .13, d = .56), bulimia (t(8)
= .21, p = .84, d = .07), self-esteem (t(6) = -.90, p = .40, d = .34), depressive symptoms (t(7) = .39, p = .71, d = .14), chest-related state anxiety (t(6) = -1.49, p = .19, d = .67), and general trait
anxiety (t(8) = -.73, p = .49, d = .24). For a table including means, standard deviations, and effect
sizes for the paired sample t-tests, see Appendix E. For a visual depiction of the data at each time
point, see Appendices F, G, H, I, and J, and for a visual depiction of individual trajectories, see
Appendices K, L, M, and N.
Model 1
The first set of mixed effects models showed significant change over time for chest
satisfaction, chest-related state anxiety, and social functioning, such that chest satisfaction and
social functioning increased, and chest-related state anxiety decreased following surgery. See
Appendix O for significant fixed effects and covariances. Fixed effects for time were not
significant for depressive symptoms = .08 (SE = .09, p = .41), general trait anxiety = -.04 (SE =
.15, p = .78), drive for thinness = -.11 (SE = .09, p = .25), bulimia symptoms = -.02 (SE = .05, p
= .70), self-esteem = .00 (SE = .07, p = .98), appearance evaluation = .03 (SE = .02, p = .07),
health-related quality of life = .06 (SE = .27, p = .82), bodily pain = .26 (SE = .43, p = .55),
general health = -.20 (SE = .38, p = .60), vitality = .23 (SE = .36, p = .53), role emotional = .19
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(SE = .50, p = .70), and mental health = .04 (SE = .36, p = .92). Taken together, these findings
indicate that while social and chest-specific outcomes improved, broader indices of mental health
such as depressive symptoms, general trait anxiety, and self-esteem did not significantly change
following gynecomastia surgery. Additionally, attitudes and behaviors associated with eating
pathology were not significantly influenced following gynecomastia surgery. Lastly, overall
health-related quality of life, including various physical and emotional aspects of quality of life,
did not significantly change following gynecomastia surgery.
Model 2
The second set of mixed effects models showed significant change over time for chest
satisfaction, chest-related state anxiety, and social functioning, such that chest satisfaction and
social functioning increased and chest-related state anxiety decreased following surgery, even
with the addition of baseline BMI entered into the model. Baseline BMI was also a significant
predictor of eating attitudes and behaviors associated with drive for thinness (aggregated across
all time points), but drive for thinness did not significantly change over time. See Appendix P for
significant fixed effects and covariances. After controlling for baseline BMI, fixed effects for
time were not significant for depressive symptoms = .07 (SE = .09, p = .48), general trait anxiety
= -.05 (SE = .15, p = .75), drive for thinness = -.10 (SE = .09, p = .28), bulimia symptoms = -.02
(SE = .05, p = .74), self-esteem = .00 (SE = .07, p = .98), appearance evaluation = .03 (SE = .02,
p = .07), health-related quality of life = .07 (SE = .27, p = .79), bodily pain = .24 (SE = .43, p =
.58), general health = -.20 (SE = .38, p = .61), vitality = .29 (SE = .37, p = .44), role emotional =
.22 (SE = .50, p = .66), and mental health = .07 (SE = .37, p = .85). Taken together, these
findings indicate that changes over time for chest-specific indices of body image and general
social functioning were not better accounted for by baseline BMI, and that baseline BMI was a
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better predictor of eating pathology than time. Lastly, findings related to health-related quality of
life and other indices of mental health remained unchanged from Model 1.
Model 3
A significant interaction of time and baseline BMI was observed for vitality as an index
of health-related quality of life. This association was only significant for individuals with a
higher baseline BMI (b = 1.46, p < .05), such that individuals with higher baseline BMI saw
improvement in vitality over time. There was not a significant association for individuals with
average BMI (b = .61, p = .13) or lower BMI (b = -.25, p = .54). See Appendix Q for significant
fixed effects and covariances and Appendix R for a graph of the interaction effect. No effect of
time by baseline BMI was observed for depressive symptoms = -.05 (SE = .04, p = .17), chestrelated state anxiety = -.13 (SE = .10, p = .22), general trait anxiety = -.07 (SE = .06, p = .30),
drive for thinness = .02 (SE = .04, p = .50), bulimia symptoms = .00 (SE = .02, p = .98), selfesteem = .04 (SE = .03, p = .16), appearance evaluation = .00 (SE = .01, p = .87), chest
satisfaction = .01 (SE = .01, p = .29), health-related quality of life = .06 (SE = .11, p = .61),
bodily pain = -.05 (SE = .18, p = .80), general health = -.09 (SE = .14, p = .54), social functioning
= -.14 (SE = .19, p = .46), role emotional = .28 (SE = .20, p = .18), and mental health = .06 (SE =
.15, p = .70). Taken together, these findings indicate that changes over time for chest-specific
indices of body image and general social functioning are not moderated by baseline BMI.
However, there was a moderator effect of baseline BMI on changes in vitality over time, such
that only individuals with higher baseline BMI saw significant improvement in vitality.
Aim 2
Based on Bartlett’s test of sphericity (χ2 = 1579.94, df = 28, p < .001; χ2 = 1233.87, df =
28, p < .001) and the Kaiser-Meyer-Olkin value (.93 and .91) for all men and women
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respectively, the CSQ items were deemed appropriate for factor analysis. The eigenvalues, scree
plot, and parallel analysis using 1000 samples suggested a 1 factor solution for both men and
women. The scale contained eight items that strongly loaded (e.g., .40 or higher) on the one
factor for both men and women (see Appendix S for pattern coefficients). Additionally, Tucker’s
coefficient of congruence (1.00) suggested an identical factor structure of the CSQ for both men
and women.
Results from the independent samples t-tests showed significant differences between men
and women on a number of variables: age (t(242.16) = 8.22, p < .001, g = .85), BMI (t(486) =
3.47, p < .01, g = .32), chest satisfaction (t(348.81) = -7.73, p < .001, g = .73), appearance
evaluation (t(470) = -2.03, p < .05, g = .18), drive for thinness (t(470) = -3.85, p < .001, g = .36),
trait anxiety, (t(443) = -2.35, p < .05, g = .23), self-esteem (t(401.36) = 2.73, p < .01, g = .26),
and general health (t(450) = 2.79, p < .01, g = .27). The following variables were not
significantly different between men and women: bulimia (t(467) = -1.63, p = .10, g = .15), chestrelated state anxiety (t(341.45) = -.45, p = .65, g = .05), depressive symptoms (t(458) = -.32, p
= .75, g = .03), health-related quality of life (t(421) = 1.40, p = .16, g = .14), bodily pain (t(483)
= .71, p = .48, g = .06), vitality (t(465) = 1.86, p = .06, g = .17), social functioning (t(475) = .39,
p = .70, g = .04), role emotional (t(480) = -1.21, p = .23, g = .11), and mental health (t(474)
= .44, p = .66, g = .04). For means, standard deviations, and effect sizes for the two groups, see
Appendix T.
Lastly, a correlation matrix was created for men with gynecomastia, men without
gynecomastia, and women that included BMI, chest satisfaction, appearance evaluation, eating
pathology, chest-related state anxiety, trait anxiety, self-esteem, depressive symptoms, and
various facets of health-related quality of life. Positive correlations between chest satisfaction
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and measures of overall appearance evaluation and self-esteem and negative correlations
between chest satisfaction and measures of eating pathology and appearance anxiety provide
convergent validity. See Appendices U, V, and W for individual correlation matrices for men
with gynecomastia, men without gynecomastia, and women respectively.
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CHAPTER FIVE: DISCUSSION
Gynecomastia affects a sizeable portion of men and is a condition in which breast tissue
develops beyond average size. While the area of male body image is fairly new and the amount
of research focused on gynecomastia is sparse, past studies have identified that gynecomastia is
often accompanied by chest dissatisfaction (Ordaz & Thompson, 2015). This can also be
evidenced by the growing number of men electing to receive cosmetic surgery aimed at reducing
breast size (American Society of Plastic Surgeons, 2017). Additional studies suggest that
individuals with gynecomastia may utilize alternative strategies that mirror traditional eating
pathology in attempt to reduce breast size (Fisher & Fornari, 1990; Nuzzi et al., 2013). It is clear
that many men with gynecomastia experience distress by the appearance of their chest, but what
remains unclear is the extent to which surgical management of the condition is effective in
reducing this distress. The current study addressed this gap in the literature by examining
psychosocial functioning before and after gynecomastia surgery and generally found significant
improvement in chest-specific indices of mental health and social functioning, whereas other
indices of mental health remained unchanged. Additionally, there is a general lack of body image
measurement in the gynecomastia literature. The current study addressed this gap by assessing
both chest-specific and global body image in a treatment-seeking population and examining the
psychometrics of a chest-specific body image measure that can be used with both men and
women.
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Aim 1
In the current study, 25 men underwent breast reduction surgery and were assessed before
surgery and through 1 year after surgery with the aim of identifying potential psychosocial
benefits from breast reduction surgery. Prior to discussing the results from this study, the overall
symptom profile of the sample should be noted. First, chest-specific indices of mental health
were most severe, with chest satisfaction being significantly lower than both men with
gynecomastia in general and men without gynecomastia. Additionally, the average for chestrelated state anxiety was in the 92nd percentile when compared to population norms for adult
males in a similar age range (Spielberger, 1983). Second, overall appearance evaluation was
significantly lower than that of men without gynecomastia. Third, many areas of mental health
were comparable to that of men without gynecomastia or mild severity. For example, eating
pathology, general trait anxiety, self-esteem, depressive symptoms, and all areas of health-related
quality of life were similar to those of men without gynecomastia, suggesting a potentially
reduced symptom profile for the current sample and limiting potential for change. Taken
together, these characteristics suggest a sample that is highly concerned with the appearance of
their chest that may not be experiencing as much distress or impairment outside of body image
factors. Additionally, examination of the individual trajectories of participants suggests a fairly
variable sample in both baseline scores and trajectories for most measures outside of chest
satisfaction. This may indicate the potential for moderators of symptom presentation and
outcomes that aren’t currently accounted for. Moreover, many variables may not change linearly,
which may limit results from mixed effects models.
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Chest Satisfaction and Overall Appearance Evaluation
In support of one hypothesis, mixed-effects models showed significant improvement in
chest satisfaction from pre to one-year post surgery among men receiving surgery for
gynecomastia. Additionally, a paired samples t-test supported this result with a large effect size.
This is in line with previous research that suggests high satisfaction rates with gynecomastia
surgery (e.g., Barone et al., 2017). As men’s breast reduction surgery aims to eliminate or reduce
incongruent sex characteristics, it makes sense that the procedure would increase chest
satisfaction, especially since that dissatisfaction is often tied concerns of a feminine appearance
(Schonfeld, 1962; Wassersug & Oliffe, 2009). While the CSQ is newer and without clinical
cutoffs, mean levels were significantly lower than both the larger sample of men with
gynecomastia and men without gynecomastia and were brought up to levels that appear similar
to those of men without gynecomastia by the 12-month follow-up. Clinically, this suggests that
surgery may have the ability to bring chest satisfaction up to more normal levels.
Chest satisfaction significantly improved over time even after controlling for baseline
BMI, and baseline BMI had no significant effect on the magnitude of improvement. It is not
uncommon for a patient’s weight to be a factor in determining eligibility for gynecomastia
surgery, as individuals who are of normal weight are less likely to experience complications or
dissatisfaction with surgery (American Society for Plastic Surgeons, 2019). While this may still
hold true for reducing surgical complications, the current study suggests that individuals may
feel better about the appearance of their chest after surgery regardless of their pre-operation
BMI. This is in line with previous retrospective research that has shown high satisfaction rates
and reductions in psychological distress after gynecomastia surgery, regardless of BMI (Rosen et
al., 2010). However, individuals who received gynecomastia surgery in the current study had an
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average baseline BMI of 25.75, which is just outside of normal range, and no one in the sample
was classified as obese based on their BMI, making the sample fairly limited in BMI range. As
complication rates tend to be higher with individuals with obesity (American Society for Plastic
Surgeons, 2019), BMI may serve as a moderator of psychological surgery outcomes, such that
individuals with greater BMI may report less improvement in chest satisfaction. Future research
should include both a broader range of BMIs and assess complication rates to see how outcomes
differ based on these factors.
Alternatively, it may be that BMI is not strongly associated with psychological outcomes
of gynecomastia surgery. BMI is often noted as a poor estimate of body fat for individuals with a
significant amount of lean mass, as it does not differentiate between fat and fat free mass (Garn,
Leonard, & Hawthorne, 1986). It is not uncommon for bodybuilders, a particularly muscular
population, to struggle with gynecomastia and seek treatment (Blau & Hazani, 2015). Future
research that includes this population may benefit from using fat free mass index, an indicator of
health similar to BMI that includes an assessment of fat mass, as it may be a more accurate
indicator of health for this significant subpopulation.
While improvements in chest satisfaction were evident over time, overall appearance
evaluation did not significantly change following gynecomastia surgery. Appearance evaluation
can be thought of as a broader index of how one view’s their body (e.g., is my body sexually
appealing) rather than a chest-specific measure. These findings indicate that while surgery may
affect local body image (e.g., for the chest), it may be less effective for changing one’s overall
body image. There is consistent previous research indicating chest satisfaction is associated with
overall body image for men (Tantleff-Dunn & Thompson, 2000), and correlations within the
current study show a high correlation between chest satisfaction and overall appearance
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evaluation in men without gynecomastia. The same correlation is smaller, though still high, when
using a sample of men with gynecomastia. This may suggest that for men with gynecomastia,
there are other factors that play into overall appearance concerns and improved chest satisfaction
via surgical removal of gynecomastia may not be enough to change this. In contrast, the paired
samples t-test showed a significant large effect size for appearance evaluation. When coupled
with the fact that the effect of time on appearance evaluation was approaching significance (p
= .07), this may suggest alternative explanations. One possibility might be that change is
nonlinear for appearance evaluation. It may be that changes occur more rapidly the farther out
from surgery when recovery is further a long, and until then, it is harder for individuals to feel
strongly about their body. These findings may also be due to random error. Future research
should continue to examine more global aspects of body image within the context of treatment
for this population.
Chest-related State Anxiety and General Trait Anxiety
One exploratory aim of the current study was to examine other factors that might be
influenced by surgical management of gynecomastia. Previous literature has shown that
individuals with gynecomastia experience anxiety about how their chest appears (Kinsella et al.,
2012), yet no study to date has examined this within the context of treatment. Similar to chest
satisfaction, mixed effects models showed significant reductions in chest-related state anxiety
from pre to one-year post surgery. That is, as time passed after surgery, men reported feeling less
nervous when their chest was exposed (e.g., wearing a thin shirt, a tight shirt, or no shirt at all).
Moreover, these effects remained significant even after controlling for BMI, and BMI had no
significant moderating effect of symptom reduction following surgery. This may suggest that
there is something unique about the presentation of breast tissue that produces anxiety regardless
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of fat mass. Additionally, chest-related state anxiety on average was in the 92nd percentile
compared to population norms for adult males between the ages of 19 and 39 (Spielberger, 1983)
and dropped to the 78th percentile by 12 month follow up. While no norms exist for the
gynecomastia population, this is a group of individuals similar in age and gender, and this jump
in percentile rank might suggest clinically significant change. In contrast however, there was no
significant change when looking at t-tests. It’s unclear why this was the case, but one possibility
might be attributable to random error. This is heightened by the fact that many of the paired
samples t-tests had very small sample sizes due to missing data.
Previous research has shown that individuals with gynecomastia often go at great lengths
to hide the appearance of their chest via means of using duct tape, extra layers of clothing, or
social withdrawal (Kinsella et al., 2012; Rosen et al., 2010; Schonfeld, 1962). These
camouflaging and avoidance behaviors may be anxiety driven and may be similar to those
exhibited by individuals with body dysmorphic disorder (BDD) in attempt to escape judgment
from others (Oakes, Collison, & Milne-Home, 2017). If breast reduction surgery is able to reduce
appearance anxiety relevant to chest exposure, it may also be able to reduce the frequency of
camouflaging and avoidance behaviors associated with gynecomastia. These findings highlight
the potential for surgery to reduce hiding behaviors associated with gynecomastia; however,
future research is needed to clarify the extent to which breast reduction is able to change
behavioral responses to appearance anxiety relevant to gynecomastia. Additional research may
also benefit from examining rates of BDD in this population and trying to distinguish between
body image-related distress associated with gynecomastia and BDD (e.g., will some individuals
still report dissatisfaction with their chest following surgery, and is this indicative of BDD?).
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While chest-related state anxiety significantly decreased over time, general trait anxiety
remained stable both in the mixed effects models and paired t-test. These findings make sense for
a number of reasons. Trait anxiety is a much broader construct revolving around emotional
responses and physiological sensations associated with anxiety not specific to the appearance of
the chest. It is unlikely that surgical intervention for gynecomastia will change how individuals
interact with the world more broadly. Second, mean levels of trait anxiety in the current sample
(M = 41.68) are fairly close to population norms for working adult men between the ages of 19
and 39 (M = 35.55), a similar population (Spielberger, 1983). This may indicate fairly normal
levels of trait anxiety in men with gynecomastia, reducing potential for change. This is also
consistent with the overall findings from this study that suggest broader constructs remain
unchanged following gynecomastia surgery.
Depression, Self-esteem, and Eating Pathology
Depressive symptoms and low self-esteem are commonly reported problems associated
with gynecomastia (e.g., Ordaz & Thompson, 2015). Past research is unclear as to whether or not
self-esteem improves following gynecomastia surgery, and no research has yet to examine
change in depressive symptoms within the context of treatment for gynecomastia. Given this
information, mixed effects models for depressive symptoms and self-esteem following
gynecomastia surgery were exploratory in nature. Results from the mixed effects models and
paired t-tests showed that depressive symptoms and self-esteem did not significantly change over
time. At baseline, the sample endorsed mild depressive symptoms based on common cutoff
scores (Kroenke, Spitzer, & Williams, 2001) and self-esteem was within the 41st percentile for
population norms in the United States (Sinclair et al., 2010). When combined with the fact that
the current sample’s scores did not significantly differ from those of men without gynecomastia,
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one explanation is that depression and self-esteem might not have much potential to change.
Additionally, depression and self-esteem are broad constructs that can be affected by a number
of factors (e.g., appearance, life events, achievements, relationships, etc.). It may be that chest
satisfaction only partially contributes to depressive symptoms or makes up a small portion of
one’s self-esteem, even for individuals with gynecomastia who are actively seeking treatment in
hopes of improving their appearance. This possibility aligns with the general findings from this
study that suggests that broader constructs remain relatively unchanged compared to chestspecific constructs (e.g., chest satisfaction and chest-related anxiety). The current study adds to
the small handful of studies that have used a validated measure to examine changes in selfesteem for this population (e.g., Barone et al., 2017). Previous research that has examined selfesteem following gynecomastia surgery has used proxy measures (e.g., questions that may not
directly assess self-esteem) or unvalidated measures (Fricke et al., 2017; Kasielska &
Antoszewski, 2011), which contribute to the mixed findings in this area. It is important for future
research to consider this limitation and use a validated measure of self-esteem or more specific
aspects of self-esteem related to appearance.
A number of studies have shown that men with gynecomastia exhibit eating pathology,
often as a means to try and self-treat the condition (e.g., Ordaz & Thompson, 2015). As a result,
it was expected that men presenting for treatment in this study might endorse high levels of
eating pathology, but this was not the case. Mean bulimia scores were minimal and drive for
thinness was only slightly more elevated. Additionally, changes in drive for thinness were better
accounted for by BMI and did not significantly change over time. While the current sample may
not have endorsed significant levels of eating pathology, future research is warranted. Eating
disorders often center around body image concerns, and previous research has highlighted eating
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concerns for this population (e.g., Ordaz & Thompson, 2015). It may be that specific subpopulations exist that are more prone to develop eating pathology in response to gynecomastia
(e.g., athletic populations or younger populations trying to self-treat), and perhaps findings with
those population may be different. It may also be that traditional eating pathology measures do
not adequately capture disordered eating or body-related behaviors for this population, and
qualitative research might be able to shed light on this area. Moreover, it may be more
appropriate to assess BDD and its associated behaviors (e.g., camouflaging, avoidance) in this
population.
Health-related Quality of Life
Past research has shown improvements in several facets of health-related quality of life
following gynecomastia surgery (Davanco et al., 2009), and based on this information, it was
hypothesized that participants would endorse significant improvements in health-related quality
of life. In partial support of this hypothesis, mixed-effects models showed significant
improvements in the social functioning domain of quality of life. Moreover, this improvement
appears to be clinically significant based on the minimally important differences suggested by
the measure’s manual (e.g., 3 point change; Maurish, 2011). Based on the fixed effect of time,
this would suggest that individuals were seeing clinically significant change in social functioning
by month three. One caveat however is that these minimally important differences are based on
lower mean scores, and research with other medical conditions have cited much larger scores
being needed to be clinically significant (Wyrwich, Tierney, Babu, Kroenke, & Wolinsky, 2005).
These results when coupled with the significant change in chest-related state anxiety may
suggest clinically significant change however.
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Social withdrawal is one of the more commonly cited coping mechanisms for individuals
with gynecomastia (e.g., Ordaz & Thompson, 2015), as these individuals often fear judgment
from others based on their appearance. These findings suggest that surgical correction of
gynecomastia has the potential to increase social behaviors over time. One plausible explanation
of these findings may be linked to how men compare themselves to others, as it is not uncommon
for men to compare their appearance to that of other men. Previous research highlights that social
comparisons are associated with body dissatisfaction (e.g., Myers & Crowther, 2009) and that
body image concerns are indicative of social withdrawal, especially in the gynecomastia
population (e.g., Ordaz & Thompson, 2015). Drawing from social comparison theory, which
posits that individuals may make evaluations about their own self or social worth from
comparisons with others (Festinger, 1954), it may be that men evaluate their own chest more
favorably following surgery, reducing distress associated with social interactions. This makes
sense in the current sample given the increases in chest satisfaction and corresponds well with
previous research that highlights body image improvements leading to greater social functioning
in women with macromastia following surgery (Perez-Panzano et al., 2017). It is also possible
that drops in chest-related anxiety are driving the increased social behavior, as individuals may
be less worried about how others view their chest. Future research on the role that social
comparisons and appearance anxiety play in social adjustment and body image in this population
is warranted however, as this goes beyond the scope of the current study.
Mixed-effects models also revealed a moderating effect of baseline BMI on changes in
vitality over time, such that vitality significantly improved for individuals with higher baseline
BMI but not for those with average or lower levels. Vitality is a measure of energy levels, and
findings from the current study are consistent with previous research that has examined health-
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related quality of life following gynecomastia surgery (Davanco et al., 2009). Vitality in the
current study however did not significantly improve until baseline BMI was entered into the
model as a potential moderator, suggesting that these effects may be dependent on BMI. For
example, it may be that individuals with higher BMI feel more energized following surgery for a
variety of reasons, whereas those with lower BMI may not see those benefits. BMI did not
significantly decrease following surgery, suggesting changes in weight are not accounting for
changes in vitality and that perhaps other factors might be responsible. Increased energy is
consistent with increased social functioning also exhibited by the current sample; however, it is
unclear the relationship between these two variables. For example, it may be that individuals
with higher BMI feel more able to engage in social behaviors due to increased energy, or it could
be that by engaging in more social behaviors, these individuals feel more energized. It could also
be that individuals with higher BMI may have more depressive symptoms and lower energy,
producing more potential for change. Additionally, anxiety can be mentally taxing, and chestrelated anxiety was heightened in this sample. Reductions in chest-related anxiety might also be
freeing up energy and mental resources for these individuals, leading individuals with higher
BMI, whose weight might also impact energy levels, to feel greater effects from these changes.
Future research should further examine the interplay between energy levels and other variables
within this population.
All other facets of health-related quality of life remained unchanged in the current study,
which is inconsistent with previous research that showed many physical and mental facets of this
construct changing over time (Davanco et al., 2009; Kasielska-Trojan & Antoszewski, 2017;
Nuzzi et al., 2018). Differences in statistical tests used and age may be accounting for these
differences. For example, Wilcoxon’s nonparametric test was used to assess change in previous
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research which is a less stringent statistical test involving fewer time points (Davanco et al.,
2009; Kasielska-Trojan & Antoszewski, 2017). Additionally, younger age has been more
indicative of quality of life improvement for individuals with gynecomastia, and mean age of the
current sample (e.g., 32.04) is substantially older compared to previous research in this area (e.g.,
17.0; Nuzzi et al., 2018). Most notably, mental health aspects of health-related quality of life
remained unchanged following surgery. While one might expect this to be impacted by surgery,
it is again a very broad measure of mental health, and broader constructs in the current sample
remained relatively stable before and after surgery. Previous research that has seen significant
change in broader constructs has asked participants to consider how those constructs changed
relative to their gynecomastia (Kasielska & Antoszewski, 2011), whereas the current sample did
not. It may be that asking participants to consider problems as they relate to their gynecomastia
may influence outcomes, and this could be something to consider for future research. Moreover,
at baseline, most aspects of quality of life in the current sample were noticeably higher than
general population norms for the United States (Maglinte, Hays, & Kaplan, 2012), which may
again suggest a lower severity symptom profile for the current sample.
Overall Findings
The current study highlights a number of novel findings regarding psychosocial
functioning following gynecomastia surgery. First, there was a general trend toward significant
change in chest-specific indices of mental health (e.g., chest satisfaction and chest-related
anxiety) following surgery whereas broader constructs generally remained the same (e.g., trait
anxiety, depressive symptoms, self-esteem, eating pathology, and health-related quality of life).
These findings may be in part due to the specificity of gynecomastia surgery, or the generally
low level of symptom severity for broader constructs in the current clinical sample. Additionally,
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social functioning significantly improved following surgery, which makes sense given that social
withdrawal is a commonly noted maladaptive coping mechanism for individuals with
gynecomastia (e.g., Ordaz & Thompson, 2015). This indicates that chest-related facets of mental
health may be more impacted by surgery versus broader constructs. While many outcome
measures do not have clinical cutoffs, a few factors show potentially clinically significant
improvement. This potential can be seen in chest satisfaction that closely mirrors that of men
without gynecomastia, chest-related anxiety percentile ranking changes, and social functioning
changes meeting less conservative estimates of minimally important differences.
Aim 2
Given the high rates of gynecomastia surgery and the specific goal of improving chest
appearance through gynecomastia surgery, a psychometrically strong chest-specific body image
measure is warranted. The CSQ is an eight-item measure of chest satisfaction that is not specific
to muscularity or fat, but instead focuses on the general appearance of the chest, with questions
addressing things like shape, symmetry, or appearance based on clothing worn. Factor analysis
of this measure showed a one-factor solution with all items strongly loading onto the one factor.
Internal consistency for the CSQ was excellent in a large sample of men with gynecomastia;
however, it was just under acceptable when used with the smaller sample of men with
gynecomastia presenting for surgical treatment. There may be variability among individuals
presenting for treatment that reduces reliability in this case. For example, there may be
unaccounted for factors that led individuals to respond differently. Future research examining the
psychometrics of the measure within a treatment seeking context with more demographic
information is warranted. The CSQ was positively associated with overall appearance evaluation
and self-esteem and negatively associated with drive for thinness, chest-related state anxiety, and
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depressive symptoms, providing convergent validity for the measure. These results show
preliminary support for the psychometrics of the CSQ and suggest that it could be used for the
gynecomastia population to assess change in body image over time. For example, some research
has examined satisfaction rates with gynecomastia surgery (Fricke et al., 2017; Kasielska-Trojan
& Antoszewski, 2017), which can be seen as a proxy for chest satisfaction, but no other studies
to date have examined specific body image variables following surgery for this population.
Macromastia, a similar condition in which women develop excess breast tissue, has
garnered more emphasis on body image research than its male counterpart. This research has
shown similar psychosocial correlates to that of gynecomastia, such as depressive symptoms,
anxiety symptoms, and reduced self-esteem (Cerrato et al., 2012; Iwuagwu et al., 2006), and
treatment research with this population has shown body image improvements following surgery
(Borkenhagen et al., 2007; Glatt et al., 1999; Perez-Panzano et al., 2017). Body image in this
population has generally been assessed either through silhouette or digital figural ratings or more
globally, and the CSQ may be a suitable attitudinal measure for use within this population to
assess chest satisfaction following macromastia surgery. Results from the EFA show preliminary
support for this, showing an identical factor structure in a sample of women when compared to
men. Additionally, the measure has excellent reliability when used with women, and it is
positively associated with overall appearance evaluation and self-esteem and negatively
associated with drive for thinness, chest-related state anxiety, and depressive symptoms, again
providing convergent validity for the measure. As anticipated, chest satisfaction was generally
positively correlated with overall appearance evaluation and self-esteem and negatively
correlated with depressive symptoms, drive for thinness, chest-related anxiety, and trait anxiety
in all three samples. Of note, BMI was only correlated with chest satisfaction for men without
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gynecomastia. This makes sense, given that body image concerns in gynecomastia population is
more about the presence of breast tissue, whereas body image concerns for men often revolve
around muscularity and leanness, aspects of appearance that consider fat mass.
This is the first study to evaluate body image in the context of gynecomastia treatment
through psychometrically tested measurement. Previous research has identified body image
problems in this population through qualitative case reports or proxy measures (e.g., satisfaction
with surgical procedures). While these methods were important first steps, the current study
provides a chest satisfaction measure, the CSQ, with a clean factor structure and appropriate
convergent validity that could be used to increase consistency between studies. The CSQ could
provide a solution to the lack of body image measures for the gynecomastia population and could
be used to assess chest satisfaction before and after surgery. Additionally, the current study
provides strong statistical support for using this measure more broadly, including with men
without gynecomastia as well as with women. Future research should test the psychometric
properties of this measure in the macromastia population. Moreover, the current study highlights
a need to use validated and psychometrically sound measures more generally with this
population, especially when assessing body image, as many previous studies have used variable
measurements (e.g., 1-item measures, proxy-measures, etc.). The inconsistency across the few
treatment studies that currently exist may be in part due to this variability in measurement. While
the CSQ has clinical utility in that it can be used for outcomes assessment in the context of
cosmetic surgery, the psychometrics of the measure should continue to be examined, with a
confirmatory factor analysis being an appropriate next step.
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CHAPTER SIX: CONCLUSION
While psychosocial treatment research for the gynecomastia population is still growing,
there are a broad array of inconsistencies between studies. Some factors that may be contributing
to inconsistencies in the treatment literature include age, statistical methods used, and
specification of outcomes related to gynecomastia. Moreover, the gynecomastia treatment
literature is often in opposition with similar research in the macromastia population that shows
improvement to broader indices of mental health following surgery (Iwuagwu et al., 2006; PérezPanzano, et al., 2017). It is unclear why similar physical conditions associated with similar
psychosocial consequences would respond differently to surgical treatment and needs further
attention. One hypothesis is that perhaps individuals seeking gynecomastia versus macromastia
surgery have different motivations. For example, men seeking gynecomastia treatment almost
always seek breast reduction for purely cosmetic reasons. Though mental health and body image
certainly play a role, there usually are not physical health factors associated with gynecomastia,
which is underscored by low insurance coverage rates for the procedure (Nuzzi et al., 2013).
Alternatively, macromastia is often accompanied by pain (Mian, Dyson, & Ulbricht, 2019),
perhaps leading to both appearance and health motivations. These dual motivations may result in
greater improvement following surgery. Future research might benefit from also comparing
psychosocial outcomes from gynecomastia surgery to breast augmentation, as both are likely
primarily motivated by appearance concerns.
The current study is not without limitations. First, the current study is a case series study,
which is a common limitation in both the macromastia and gynecomastia literature. This lack of
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experimental nature makes it impossible to determine causal relationships. Second, the current
study lacks a comparison group. While surgery is the most common form of active treatment for
gynecomastia, previous research suggests a potential need for psychological intervention
(Schonfeld, 1962). Future experimental research that compares the effectiveness of surgery to
other treatments (e.g., psychotherapy) or lack of treatment is warranted. Third, BMI is commonly
associated with outcomes in the gynecomastia literature (e.g., Ordaz & Thompson, 2015), and
the current study exhibited a restricted range in BMI. The average BMI for individuals in the
treatment-receiving group was just outside the healthy weight range with little variability across
participants. This restricted range in BMI may have influenced results, especially when
considering BMI as a potential moderator of outcomes. Additionally, there may be other
moderators of outcomes that this study failed to capture. Lastly, the small sample size limiting
available statistical procedures (e.g., follow-up reliability and p value adjustments) and
substantial missing data potentially biasing results are notable limitations tied to the difficulty in
recruiting a clinical sample and collecting follow-up data in a fast-paced medical environment.
In conclusion, the current study adds to the gynecomastia treatment literature by
examining longitudinal change in body image-related variables before and after surgery.
Additionally, the current study provides a psychometrically valid measure of chest satisfaction
that can be used for not only the gynecomastia population but other populations as well (e.g.,
men without gynecomastia and women). Results from the current study suggest that surgery has
the potential to improve chest satisfaction and psychological functioning, especially in chestspecific measures and social functioning but that broader constructs may require additional
intervention. Future research is needed to examine causal effects of surgery for gynecomastia on
psychosocial functioning and to examine other types of intervention such as psychotherapy.
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APPENDIX A:
TIMELINE OF STUDY TIME POINTS
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APPENDIX B:
GYNECOMASTIA.ORG FORUM POST
Hello,
My name is Daniel Luis Ordaz, and I am principal investigator in a research study titled:
Psychological Correlates of Gynecomastia (Pro_16403). This study is being conducted through
the University of South Florida, under the supervision of Dr. Kevin Thompson. The purpose of
this study is to examine psychological and social factors related to gynecomastia, as very little
research has been conducted in this area despite some evidence suggesting the psychological
impact of gynecomastia. This study will hopefully shed some light on the effects of
gynecomastia as well as inform future treatment of gynecomastia.
This study is being conducted solely online and consists of several questionnaires that
take about 20 minutes to complete. All information is strictly confidential, and participation is
completely voluntary. Please do not feel that you have to participate in this study because you
have read this or are a member of this forum. However, if you are a male with gynecomastia
aged 18 years or older, and are interested in participating in this study, please follow the link
below to participate in the study.
Study Link: https://www.surveymonkey.com/s/ZL5ZZ27
Thanks,
Daniel Luis Ordaz, B.A.
Clinical Psychology Doctoral Student
University of South Florida
Body Image Research Group
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APPENDIX C:
CHEST SATISFACTION QUESTIONNAIRE (CSQ)
Instructions: Using the scale below, please circle the number that best matches your agreement
with the following statements.
Definitely
Disagree

Mostly
Disagree

Neither agree
nor disagree

Mostly
agree

Definitely
agree

1

2

3

4

5

1. I am comfortable with the shape of my chest.

1

2

3

4

5

2. I am comfortable with the size of my chest.

1

2

3

4

5

3. I am comfortable with the symmetry of my chest.

1

2

3

4

5

4. My chest is unattractive.*

1

2

3

4

5

5. My chest looks good in motion.

1

2

3

4

5

6. I am satisfied with the appearance of my chest.

1

2

3

4

5

7. I like the way my chest looks with a shirt on.

1

2

3

4

5

8. I like the way my chest looks without a shirt on.

1

2

3

4

5
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APPENDIX D:
AIM 1 DESCRIPTIVES
Descriptives for Aim 1 Presented in Mean (SD) with Post-hoc Differences and Effect Sizes
Variable

Primary Surgery
Group
N = 18

Men with
Gynecomastia
N = 65

Men without
Gynecomastia
N = 75

η2

Age

32.04 (10.72)a

35.03 (13.32)a

20.59 (3.81)b

.34

BMI

25.75 (2.59)ab

27.23 (6.14)a

24.82 (4.76)b

.05

Chest Satisfaction

01.81 (.56)c

2.23 (1.04)b

3.56 (.89)a

.38

Appearance Evaluation

02.82 (.63)b

2.68 (.91)b

3.53 (.88)a

.18

Drive for Thinness

20.88 (8.36)ab

22.79 (8.40)a

17.37 (8.36)b

.09

Bulimia Symptoms

11.96 (4.53)

14.73 (8.67)

12.53 (5.61)

.03

Chest-related State
Anxiety

52.83 (14.32)a

50.22 (16.52)a

38.14 (13.17)b

.16

Trait Anxiety

41.68 (10.39)ab

44.75 (14.58)a

39.60 (12.37)b

.03

Self-esteem

21.48 (4.72)ab

19.11 (6.92)b

22.06 (6.25)a

.05

Depressive Symptoms

05.00 (3.73)b

7.48 (5.96)a

5.85 (5.52)ab

.03

Health-related Quality
of Life

70.25 (15.44)

63.09 (17.41)

66.93 (13.76)

.02

Bodily Pain

89.38 (14.66)a

77.08 (23.95)b

82.14 (17.47)ab

.05

General Health

75.68 (14.74)

69.18 (20.63)

69.80 (17.19)

.01

Vitality

56.75 (16.13)

50.41 (19.07)

52.27 (17.39)

.01

Social Functioning

69.50 (31.89)ab

61.96 (31.11)b

76.62 (22.16)a

.06

Role Emotional

71.00 (24.78)

62.46 (25.03)

66.44 (24.59)

.01

Mental Health

67.00 (16.89)

60.33 (22.35)

66.28 (18.30)

.01

Note. Surgery group measures are from baseline. The sample of men with gynecomastia includes the
surgery group of men. Superscript letters indicate significant differences based on post-hoc tests. Age,
BMI, chest satisfaction, bulimia, depressive symptoms, bodily pain, and social functioning used GamesHowell post-hoc. All others used Tukey HSD. Significance values based on p < .05. η2 = eta-squared
effect size.
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APPENDIX E:
AIM 1 PAIRED T-TESTS
Paired Samples t-Test Means, Standard Deviations, and Effect Sizes for the Surgery Group
Variable
BMI
Chest Satisfaction***
Appearance Evaluation**
Drive for Thinness
Bulimia Symptoms
Chest-related State Anxiety
Trait Anxiety
Self-esteem
Depressive Symptoms
Health-related Quality of Life
Bodily Pain
General Health
Vitality
Social Functioning
Role Emotional
Mental Health

Baseline

12 MFU

d

n

24.57 (2.61)
1.77 (.77)

24.89 (2.85)
3.27 (.88)

.31
1.69

10
10

2.40 (.41)
20.89 (8.55)
11.67 (3.67)
43.00 (14.32)

3.02 (.42)
18.56 (6.62)
11.33 (4.61)
50.43 (14.62)

1.65
.13
.07
.67

9
9
9
7

38.56 (11.24)
20.57 (4.79)
5.63 (4.98)

42.56 (13.56)
22.57 (4.43)
6.88 (6.37)

.24
.34
.14

9
7
8

71.99 (17.53)
93.06 (11.84)
80.63 (10.84)

69.49 (18.17)
88.89 (22.50)
73.75 (21.17)

.20
.21
.38

8
9
8

54.17 (21.65)
70.83 (36.98)
71.30 (27.36)
64.44 (18.28)

52.08 (20.73)
81.94 (23.48)
67.59 (32.39)
62.78 (18.05)

.13
.40
.13
.12

9
9
9
9

Note. 12 MFU = 12-month follow up. Scores presented as M (SD). d = Cohen’s d. **p < .01, ***p < .001.
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APPENDIX F:
MEAN CHEST SATISFACTION AND APPEARANCE EVALUATION SCORES OVER TIME
5
4.5
4
3.5
3
2.5
2
1.5
1
Baseline

1 MFU

3 MFU
Chest Satisfaction

6 MFU

12 MFU

Appearance Evaluation

Note. This graph shows mean scores for the above variables at each time point. The scale for each measure
ranges from 1 to 5, with higher scores indicating greater body image. # MFU = respective month follow up.
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APPENDIX G:
MEAN STATE AND TRAIT ANXIETY SCORES OVER TIME
80

70

60

50

40

30

20
Baseline

1 MFU

3 MFU
State Anxiety

6 MFU

12 MFU

Trait Anxiety

Note. This graph shows mean scores for the above variables at each time point. The scale for each measure
ranges from 20 to 80, with higher scores indicating greater anxiety. # MFU = respective month follow up.
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APPENDIX H:
MEAN DRIVE FOR THINNESS AND BULIMIA SCORES OVER TIME
42

37

32

27

22

17

12

7
Baseline

1 MFU

3 MFU

6 MFU

Drive for Thinness

12 MFU

Bulimia

Note. This graph shows mean scores for the above variables at each time point. The scale for each measure
ranges from 7 to 42, with higher scores indicating greater eating pathology. # MFU = respective month
follow up.
58

APPENDIX I:
MEAN DEPRESSION AND SELF-ESTEEM SCORES OVER TIME
30

25

20

15

10

5

0
Baseline

1 MFU

3 MFU
Self-esteem

6 MFU

12 MFU

Depressive Symptoms

Note. This graph shows mean scores for the above variables at each time point. The scale for the self-esteem measure
ranges from 0 to 30, with higher scores indicating greater self-esteem. The scale for the depression measure ranges from
0 to 27, with higher scores indicating more depressive symptoms. # MFU = respective month follow up.
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APPENDIX J:
MEAN HEALTH-RELATED QUALITY OF LIFE SCORES OVER TIME
100
90
80
70
60
50
40
30
20
10
0
Baseline

1 MFU

3 MFU

6 MFU

Health-related QoL

Bodily Pain

General Health

Social Functioning

Role Emotional

Mental Health

12 MFU

Vitality

Note. This graph shows mean scores for the above variables at each time point. The scale for each measure ranges from 0 to 100,
with higher scores indicating greater quality of life in each domain. # MFU = respective month follow up, QoL = quality of life.
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APPENDIX K:
INDIVIDUAL TRAJECTORIES FOR THE CSQ, MBSRQ-AE, EDI-DT, AND EDI-B

Note. Plots show individual data points over time for chest satisfaction (top left), appearance evaluation (top right),
drive for thinness (bottom left), and bulimia (bottom right). Missing data was interpolated when possible.
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APPENDIX L:
INDIVIDUAL TRAJECTORIES FOR THE RSES, PHQ-9, STAI-S, AND STAI-T

Note. Plots show individual data points over time for self-esteem (top left), depression (top right), chest-related
state anxiety (bottom left), and general trait anxiety (bottom right). Missing data was interpolated when possible.
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APPENDIX M:
INDIVIDUAL TRAJECTORIES FOR THE SF-36 V2 AND BP, GH, AND VT SUBSCALES

Note. Plots show individual data points over time for overall health-related quality of life (top left), bodily pain
(top right), general health (bottom left), and vitality (bottom right). Missing data was interpolated when possible.
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APPENDIX N:
INDIVIDUAL TRAJECTORIES FOR THE SF-36 V2 SUBSCALES OF SF, RE, AND MH

Note. Plots show individual data points over time for social functioning (top left), role emotional (top right), and
mental health (bottom left). Missing data was interpolated when possible.
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APPENDIX O:
MODEL 1 FIXED EFFECTS
Significant Fixed Effects and Variance/Covariances for Model 1
Chest Satisfaction
Fixed Effects

Chest-related State Anxiety

Social Functioning

Est

SE

p

Est

SE

p

Est

SE

p

Intercept

2.37

.17

<.001

46.57

2.41

<.001

69.10

4.90

<.001

Months

0.12

.03

<.001

0-.79

0.26

<.010

01.35

0.46

<.010

Intercept

.08

.30

.80

099.93

38.41-

0<.0100

493.55

170.90

<.010

AR1 diagonal

.90

.35

<.050

117.92

028.59

0<.0010

214.71

045.72

<.001

AR1 rho

.32

.33

.33

00-.65

0.13

<.001

00-.10

000.23

.66

Variance/Covariances

Note. All other measures were non-significant.
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APPENDIX P:
MODEL 2 FIXED EFFECTS
Significant Fixed Effects and Variance/Covariances for Model 2
Chest Satisfaction
Fixed Effects

Chest-related State Anxiety

Social Functioning

Drive for Thinness

Est

SE

p

Est

SE

p

Est

SE

p

Est

SE

p

Intercept

1.64

1.40

.25

52.25

22.52

<.05

37.86

46.74

.43

-12.45

14.71

.41

Months

.12

.03

<.01

-.80

.26

<.01

1.37

.46

<.01

-.10

.09

.28

BMI

.03

.05

.61

-.22

.88

.80

1.22

1.82

.51

1.28

.57

<.05

Intercept

.03

.36

.93

97.85

38.87

<.05

472.25 169.43

<.01

51.18

15.43

<.01

AR1 diagonal

.95

.42

<.05

119.02

29.47

<.001

216.78

46.66

<.001

9.18

1.85

<.001

AR1 rho

.36

.36

.29

-.65

.13

<.001

-.10

.24

.66

-.27

.26

.30

Variance/Covariances

Note. BMI = baseline BMI. All other measures were non-significant.
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APPENDIX Q:
MODEL 3 FIXED EFFECTS
Significant Interaction Effects and Variance/Covariances for Model 3
Vitality
Fixed Effects

Est

SE

p

Intercept

24.47

33.02

.46

Months

-7.89

3.62

<.05

BMI

1.25

1.28

.34

MonthsxBMI

.33

.15

<.05

Intercept

188.92

80.14

<.05

AR1 diagonal

117.71

47.39

<.05

.39

.28

.16

Variance/Covariances

AR1 rho

Note. BMI = baseline BMI. All other measures were non-significant.
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APPENDIX R:
INTERACTION EFFECT FOR TIME X BASELINE BMI ON VITALITY
100

90
80
70
60
50
40
30
20
10
0
Baseline 1 Month

3
Months

6
Months
Low BMI

Average BMI

12
Months
High BMI

Note. This graph shows predicted vitality scores based on the interaction effect of time by
baseline BMI. Vitality scores can range from 0 to 100 with higher scores indicating greater
quality of life related to vitality. Average BMI is the average baseline BMI (25.75), while high
(28.34) and low BMI (23.16) are one standard deviation above and below the mean respectively.
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APPENDIX S:
EFA PATTERN COEFFICIENTS, EIGENVALUES, AND PERCENT VARIANCE
Pattern Coefficients, Eigenvalues, and Percent Variance for the CSQ in Men and Women
Items

Men

Women

1. I am comfortable with the shape of my chest.

.895

.771

2. I am comfortable with the size of my chest.

.855

.845

3. I am comfortable with the symmetry of my chest.

.711

.624

4. My chest is unattractive.

.689

.616

5. My chest looks good in motion.

.795

.576

6. I am satisfied with the appearance of my chest.

.930

.890

7. I like the way my chest looks with a shirt on.

.841

.803

8. I like the way my chest looks without a shirt on.

.901

.773

Eigenvalues

5.53

4.44

Percent Variance

69.09

55.51

Note. Factor loadings and eigenvalues obtained using principal axis factoring with promax
oblique rotation. All factor loadings were > .40.
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APPENDIX T:
AIM 2 INDEPENDENT T-TESTS
Independent Samples t-Tests Means, Standard Deviations, and Effect Sizes for Men and Women
Variable

Men

Women

g

Age***

27.39 (11.96)

20.30 (4.03)

.85

BMI**

25.96 (5.57)

24.28 (5.05)

.32

Chest Satisfaction***

2.94 (1.17)

3.66 (.83)

.73

Appearance
Evaluation*

3.14 (.99)

3.31 (.88)

.18

Drive for Thinness***

19.86 (8.78)

23.19 (9.59)

.36

Bulimia Symptoms

13.53 (7.23)

14.63 (7.11)

.15

Chest-related State
Anxiety

43.53 (15.90)

44.17 (12.55)

.05

Trait Anxiety*

41.92 (13.62)

44.84 (12.34)

.23

Self-esteem**

20.69 (6.72)

19.06 (5.97)

.26

Depressive Symptoms

6.61 (5.77)

6.78 (5.47)

.03

Health-related Quality
of Life

65.21 (15.57)

63.08 (15.49)

.14

Bodily Pain

79.79 (20.83)

78.46 (20.24)

.06

General Health**

69.52 (18.79)

64.34 (19.87)

.27

Vitality

51.42 (18.15)

48.25 (18.30)

.17

Social Functioning

69.88 (27.57)

68.91 (26.59)

.04

Role Emotional

64.57 (24.82)

67.33 (24.64)

.11

Mental Health

63.58 (20.41)

62.77 (18.95)

.04

Note. The sample of men is a combined sample of all groups of men in the study. The
assumption of equal variances was violated for age, chest satisfaction, chest-related state anxiety,
and self-esteem based on Levene’s test. g = Hedge’s g. n ranged between 179 and 208 for men
and 244 and 280 for women per analysis. *p < .05, **p < .01, ***p < .001.
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APPENDIX U:
GYNECOMASTIA CORRELATION MATRIX
Correlation Matrix for Study Variables in a Sample of Men with Gynecomastia

BMI
CSQ
MBSRQ
EDI-DT
EDI-B
STAI-S
STAI-T
RSES
PHQ-9
SF36-V2
BP
GH
VT
SF
RE
MH

BMI

CSQ

MBSR
Q-AE

EDIDT

EDI-B

STAI-S

STAI-T

RSES

PHQ9

SF36V2

BP

GH

VT

SF

RE

MH

1

.01

-.24*

.14

.27**

.07

-.03

.08

.06

-.20

-.27**

-.22

-.10

-.03

-.02

-.07

1

.67***

-.34**

-.15

-.52***

-.47***

.38***

-.37**

.34**

-.30**

.10

.38***

.32**

.28**

.47***

1

-.38***

-.36***

-.44***

-.51***

.56***

-.42***

.42***

-.09

.18

.45***

.36***

.36***

.50***

1

.68***

.54***

.55***

-.50***

.51***

-.54***

-.11

-.23*

-.49***

-.40***

-.40***

-.56***

1

.44***

.54***

-.52***

.52***

-.55***

-.16

-.21*

-.51***

-.39***

-.39***

-.52***

1

.78***

-.66***

.65***

-.68***

-.00

-.38***

-.63***

-.52***

-.48***

-.69***

1

-.87***

.85***

-.84***

-.14

-.52***

-.79***

-.68***

-.61***

-.86***

1

-.73***

.74***

.07

.47***

.70***

.53***

.54***

.74***

1

-.84***

-.25*

-.53***

-.80***

-.69***

-.57***

-.78***

1

.43***

.76***

.88***

.77***

.69***

.88***

1

.47***

.30**

.32**

.04

.15

1

.53***

.46***

.38**

.48***

1

.61***

.55***

.84***

1

.55***

.66***

1

.55***
1

Note. BMI = Body Mass Index. CSQ = Chest Satisfaction Questionnaire. MBSRQ = Appearance Evaluation. EDI-DT = Drive for Thinness. EDI-B = Bulimia. STAI-S = Chestrelated State Anxiety. RSES = Self-esteem. PHQ-9 = Depressive Symptoms. SF36-V2 = Overall Health-related Quality of Life. BP = Bodily Pain. GH = General Health. VT =
Vitality. SF = Social Functioning. RE = Role Emotional. MH = Mental Health. n ranged from 82 to 106. *p < .05. **p < .01. ***p < .001.

APPENDIX V:
HEALTHY CONTROLS CORRELATION MATRIX
Correlation Matrix for Study Variables in a Sample of Men without Gynecomastia

BMI
CSQ
MBSRQ
EDI-DT
EDI-B
STAI-S
STAI-T
RSES

BMI

CSQ

MBSR
Q-AE

EDIDT

EDI-B

STAI-S

STAI-T

RSES

PHQ9

SF36V2

BP

GH

VT

SF

RE

MH

1

-.21*

-.21*

-.40***

.16*

.14

-.04

.02

-.07

-.01

.05

-.09

.05

.01

.04

-.04

1

.80***

-.35**

-.18

-.59***

-.44***

.44***

-.28**

.29**

-.02

.47***

.18

.14

.11

.23*

1

-.34***

-.21*

-.63***

-.55***

.60***

-.32**

.46***

.02

.59***

.34***

.17

.12

.39***

1

.45***

.43***

.38***

-.38***

.33**

-.46***

-.22*

-.35***

-.31**

-.32**

-.30**

-.41***

1

.46***

.49***

-.48***

.42***

-.53***

-.30**

-.38***

-.25**

-.42***

-.34***

-.54***

1

.72***

-.70***

.44***

-.61***

-.25*

-.57***

-.45***

-.35***

-.32**

-.59***

1

-.85***

.70***

-.82***

-.38***

-.54***

-.64***

-.55***

-.55***

-.78***

1

-.61***

.81***

.25**

.64***

.64***

.44***

.49***

.74***

1

-.71***

-.33**

-.36***

-.55***

-.62***

-.57***

-.60***

1

.46***

.67***

.75***

.71***

.72***

.87***

1

.22*

.32**

.33***

.27**

.33**

1

.42***

.23*

.24*

.45***

1

.39***

.40***

.65***

1

.60***

.65***

1

.55***

PHQ-9
SF36-V2
BP
GH
VT
SF
RE
MH

1

Note. BMI = Body Mass Index. CSQ = Chest Satisfaction Questionnaire. MBSRQ = Appearance Evaluation. EDI-DT = Drive for Thinness. EDI-B = Bulimia. STAI-S = Chestrelated State Anxiety. RSES = Self-esteem. PHQ-9 = Depressive Symptoms. SF36-V2 = Overall Health-related Quality of Life. BP = Bodily Pain. GH = General Health. VT =
Vitality. SF = Social Functioning. RE = Role Emotional. MH = Mental Health. n ranged from 93 to 110. *p < .05. **p < .01. ***p < .001.
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APPENDIX W:
WOMEN CORRELATION MATRIX
Correlation Matrix for Study Variables in a Sample of Women

BMI
CSQ
MBSRQ
EDI-DT
EDI-B
STAI-S
STAI-T
RSES

BMI

CSQ

MBSR
Q-AE

EDIDT

EDI-B

STAI-S

STAI-T

RSES

PHQ9

SF36V2

BP

GH

VT

SF

RE

MH

1

.01

-.36***

.34***

.24***

.07

.03

-.06

.04

-.03

-.13*

-.10

.02

.02

.10

-.01

1

.43***

-.15*

-.17**

-.32***

-.37***

.41***

-.24***

.25***

.04

.20**

.25***

.20**

.09

.25***

1

-.53***

-.38***

-.46***

-.46***

.57***

-.30***

.35***

.19**

.26***

.32***

.24***

.12*

.33***

1

.56***

.36***

.38***

-.43***

.35***

-.28***

-.12*

-.15*

-.25***

-.26***

-.19**

-.27***

1

.42***

.48***

-.46***

.48***

-.45***

-.15*

-.29***

-.30***

-.40***

-.34***

-.37***

1

.76***

-.67***

.56***

-.62***

-.17**

-.32***

-.52***

-.51***

-.44***

-.64***

1

-.83***

.76***

-.78***

-.20**

-.35***

-.71***

-.64***

-.55***

-.83***

1

-.68***

.66***

.21**

.34***

.59***

.52***

.45***

.66***

1

-.78***

-.37***

-.35***

-.70***

-.69***

-.58***

-.71***

1

.52***

.66***

.81***

.84***

.75***

.81***

1

.44***

.28***

.40***

.31***

.21***

1

.38***

.45***

.27***

.27***

1

.60***

.48***

.69***

1

.62***

.66***

1

.58***

PHQ-9
SF36-V2
BP
GH
VT
SF
RE
MH

1

Note. BMI = Body Mass Index. CSQ = Chest Satisfaction Questionnaire. MBSRQ = Appearance Evaluation. EDI-DT = Drive for Thinness. EDI-B = Bulimia. STAI-S = Chestrelated State Anxiety. RSES = Self-esteem. PHQ-9 = Depressive Symptoms. SF36-V2 = Overall Health-related Quality of Life. BP = Bodily Pain. GH = General Health. VT =
Vitality. SF = Social Functioning. RE = Role Emotional. MH = Mental Health. n ranged from 219 to 281. *p < .05. **p < .01. ***p < .001.
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